About
PrimeVigilance

We help emerging and established companies meet their regulatory obligations

PrimeVigilance was established in 2008 by Dr. Miroslav Reljanovic together with co-founder Dr. Elliot Brown. PrimeVigilance offers holistic, top quality, cost-effective, innovative safety services for pharmaceutical, generic and biotechnology companies. Our founders and leaders have an unrivalled reputation in the sector with a network of expert associates across the world. These include former senior regulators and consultants with extensive industry experience, especially with marketed products.

We are leading experts with experience as regulators and have run pharmaceutical or biotech companies

PrimeVigilance has grown organically since 2008 and we now have over 500 people working from our six main offices in the United Kingdom, United States, Croatia, Czech Republic, Germany and Serbia.

Our pharmacovigilance services cover all the regulatory and scientific elements required to obtain and maintain a product licence within Europe. PrimeVigilance also offers fully integrated international Medical Information services.

PrimeVigilance specialises in helping emerging companies comply with regulations, from developing the initial Detailed Description of PV Systems and RMP right through to full management of safety operations.
  • OPERATIONAL LEADERSHIP TEAM

    Meet the people behind PrimeVigilance

    PrimeVigilance is a subsidiary of Ergomed plc. and is managed by its own Board of Directors which includes leading pharmacovigilance experts

    +

  • CORPORATE SOCIAL RESPONSIBILITY

    Contributing toward a better world

    PrimeVigilance recognises that its activities and operations have a societal impact and we place a high emphasis on our social responsibilities.

    +

  • “We sincerely thank you all for your help and successful labor during this year and we are looking forward to work with you as well in the future.”

    Head Safety Processes Manager

    Global Drug Safety Section

    “Knowing I have you as partners helps me sleep soundly at night.”

    CMO and Director of Compliance

    Pharmaceutical Company

    65,800

    ICSRs/SAEs processed every year

    11,000

    Full articles reviewed every year

    430,000

    Literature abstracts reviewed every year

    800

    PSURs, DSURs, PADERs, ACOs written every year

    500

    Signal evaluation reports prepared every year

    30

    PSMFs drafted of which 22 managed in-house